Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2025
Communicable Diseases Intelligence · 21.07.2026 · 50
DOI: 10.33321/cdi.2026.50.052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Communicable Diseases Intelligence, online erschienen am 21.07.2026. Verfasst von Suzy Teutsch und 3 weiteren Autor:innen. Beteiligte Einrichtung: The University of Sydney, Faculty of Medicine and Health, Specialty of Child and Adolescent Health, Sydney, New South Wales, Australia; The Australia…. Hauptthemen laut MEDLINE: Population Surveillance, Communicable Diseases. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
For over 30 years, the Australian Paediatric Surveillance Unit (APSU) has conducted national prospective surveillance of rare conditions in children, including communicable diseases and complications, providing data that has informed changes to policy and clinical practice. In 2025, the APSU monitored seven rare communicable diseases and complications: acute flaccid paralysis (AFP); perinatal exposure to human immunodeficiency virus (HIV); paediatric HIV infection; juvenile-onset recurrent respiratory papillomatosis (JoRRP); congenital rubella infection/syndrome; congenital varicella syndrome (CVS); and neonatal varicella infection (NVI). An average of 1,313 paediatricians and other relevant clinical specialists received a report card each month listing rare conditions under APSU surveillance (including the seven described in this report), and completed a case report form for any child(ren) seen with one or more of these conditions, detailing demographics, clinical features, treatment/management, risk factors and short-term outcomes. There were 134 notifications, of which 105 were confirmed as cases, after excluding duplicate reports or errors. The annual response rate to the report card was 78.4%. The non-polio AFP incidence of 1.58 per 100,000 children aged < 15 years exceeded the World Health Organization requirement to maintain Australia’s polio-free status. Incidence of perinatal exposure to HIV remained stable, but new paediatric HIV infections increased. While there were no cases of congenital rubella or CVS, three cases of NVI and one case of JoRRP were reported, indicating ongoing gaps in vaccination despite two decades of universal vaccination in Australia. Continued APSU surveillance remains essential to assess the prevention of disease occurrence and adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The University of Sydney, Faculty of Medicine and Health, Specialty of Child and Adolescent Health, Sydney, New South Wales, Australia; The Australian Paediatric Surveillance Unit, The Sydney Children's Hospitals Networ…
Zitieren
APA
Teutsch, S., Nunez, C., Morris, A., & Elliott, E. (2026). Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2025. Communicable Diseases Intelligence, 50. https://doi.org/10.33321/cdi.2026.50.052
Vancouver
Teutsch S, Nunez C, Morris A, Elliott E. Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2025. Communicable Diseases Intelligence. 2026;50. doi:10.33321/cdi.2026.50.052
BibTeX
@article{Teutsch2026,
author = {Teutsch, Suzy and Nunez, Carlos and Morris, Anne and Elliott, Elizabeth},
title = {Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2025},
journal = {Communicable Diseases Intelligence},
year = {2026},
volume = {50},
doi = {10.33321/cdi.2026.50.052}
}
EUVIMED